PhaseRx Market Cap

PhaseRx has a market cap or net worth of $1.17 thousand as of June 6, 2025. Its market cap has decreased by -96.67% in one year.

Market Cap

1.17K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 1.17K, a decrease of -100.00%. That is a compound annual growth rate of -69.73%.

Market Cap History

Date	Market Cap	% Change
Jun 3, 2025	1.17K	-49.98%
Dec 31, 2021	2.34K	-92.59%
Dec 31, 2020	31.61K	285.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	730.27M
Nika Pharmaceuticals	666.65M
Tian'an Technology Group	614.49M
Elite Pharmaceuticals	597.81M
Glass House Brands	439.72M
CytoDyn	426.43M
Northwest Biotherapeutics	384.07M

Market Cap Rankings